Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TCT 2010: TAVI Takes Center Stage

Executive Summary

In the interventional cardiology community, 2010 could certainly be considered a breakthrough year for percutaneous heart valve devices. At two major US cardiology conferences: the American College of Cardiology in the spring, and most recently, the Transcatheter Cardiovascular Therapeutics symposium, held in September, impressive results from randomized trials of transcatheter heart valve replacement/repair devices set the venues abuzz and had physicians speculating about possible near-term paradigm shifts in the way heart valve disease will be treated. The big questions now are how long it will take before these devices reach the US market, and exactly how many US patients are likely to be implanted once they are available.

You may also be interested in...



Market & Industry Briefs

Brief summaries of recent medtech market and industry developments. This month we cover transcatheter valve news announced at ACC, Covidien's brain aneurysm device, NMT Medical closing shop, J&J's move to acquire Synthes and VisualSonics in vivo imaging technology for cancer.

Market & Industry Briefs

Brief summaries of recent medtech market and industry developments. This month we cover transcatheter valve news announced at ACC, Covidien's brain aneurysm device, NMT Medical closing shop, J&J's move to acquire Synthes and VisualSonics in vivo imaging technology for cancer.

Market & Industry Briefs

Brief summaries of recent medtech market and industry developments. This month we cover recent device M&A, Medtronic and Nile Therapeutics' collaboration in heart failure, Neoprobe and Naviscan PET Systems' deal in cancer detection, and Qiagen and Epigenomics AG's collaboration in a blood test for colorectal cancer.

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

LL1134882

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel